Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

324
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
324
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
Overview of Advanced Functional Groups02:22

Overview of Advanced Functional Groups

29.4K

Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.4K
Sample Preparation for Analysis: Advanced Techniques01:08

Sample Preparation for Analysis: Advanced Techniques

1.3K
Accurate analysis of complex samples often requires advanced preparation techniques to achieve reliable and reproducible results. Samples containing inorganic or organic materials can be challenging to dissolve or decompose effectively. Standard sample preparation methods include acid digestion, fusion, dry ashing, and wet digestion.
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
1.3K
Sustainable Development01:43

Sustainable Development

14.8K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
14.8K
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques01:30

Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

505
Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
505

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive multi-omic profiling of desmoplastic small round cell tumors identifies targetable pathways with therapeutic opportunities.

Molecular cancer research : MCR·2026
Same author

scSurvival: Single-Cell Survival Analysis of Clinical Cancer Cohort Data at Cellular Resolution.

Cancer discovery·2026
Same author

Tumor-immune trajectory context connects static tissue architecture to clinical outcomes.

bioRxiv : the preprint server for biology·2026
Same author

miniMTI: minimal multiplex tissue imaging enhances biomarker expression prediction from histology.

Research square·2026
Same author

Pan-cancer inference and validation of hypermorphic, hypomorphic and neomorphic mutations.

Nature genetics·2026
Same author

ARID1A Mediates SWI/SNF-Independent Maintenance of Heterochromatin Architecture to Restrain Viral Mimicry and Immunogenicity in Colon Cancer.

Cancer research·2026

Related Experiment Video

Updated: Jan 24, 2026

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery
05:31

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

4.6K

Advancing Drug Development in Gynecologic Malignancies.

Julia A Beaver1, Robert L Coleman2, Rebecca C Arend3

  • 1FDA Center for Drug Evaluation and Research, Silver Spring, Maryland.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|May 26, 2019
PubMed
Summary

Advancing gynecologic cancer treatment requires improved communication for immunotherapy and targeted therapies. Innovative clinical trials and understanding diagnostic tools are crucial for developing effective drugs and improving patient outcomes.

More Related Videos

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

7.5K
Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
05:24

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy

Published on: January 10, 2025

785

Related Experiment Videos

Last Updated: Jan 24, 2026

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery
05:31

OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery

Published on: May 9, 2021

4.6K
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

7.5K
Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
05:24

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy

Published on: January 10, 2025

785

Area of Science:

  • Oncology
  • Regulatory Science
  • Translational Medicine

Background:

  • Gynecologic malignancies remain a significant health burden in the US.
  • Recent oncologic therapies show promise, but improved drug development pathways are needed for immunotherapy and biomarker-driven approaches.
  • Effective communication among stakeholders is essential for advancing treatment options.

Purpose of the Study:

  • To review the state of science in gynecologic cancers.
  • To explore how scientific advances impact drug approval processes.
  • To identify challenges and foster discussion on drug development for gynecologic malignancies.

Main Methods:

  • The FDA-AACR-SGO Drug Development in Gynecologic Malignancies Workshop convened diverse stakeholders in June 2018.
  • Discussions focused on current scientific understanding and regulatory considerations.
  • Key takeaways were summarized for publication.

Main Results:

  • Single-agent immunotherapies show modest response rates in gynecologic cancers.
  • Combination therapies, cell-based therapies, and novel trial designs may enhance efficacy.
  • Distinguishing between companion and complementary diagnostics is vital for regulatory strategy.
  • PARP inhibitors show promise in ovarian cancer, and rare gynecologic cancers offer unique therapeutic targets.

Conclusions:

  • Enhanced collaboration and open dialogue are necessary to address scientific and regulatory hurdles in gynecologic cancer drug development.
  • Understanding diagnostic types and innovative trial designs are key to therapeutic advancement.
  • Future research should focus on combination strategies and targeting unique molecular characteristics of rare gynecologic cancers.